Neurofibromatosis 1

被引:4
作者
Wolkenstein, P [1 ]
机构
[1] Univ Paris 12, Hop Henri Mondor, INSERM U421, Serv Dermatol & Reseau NF Mondor, F-94010 Creteil, France
来源
M S-MEDECINE SCIENCES | 2001年 / 17卷 / 11期
关键词
D O I
10.1051/medsci/200117111158
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neurofibromatosis 1 is an autosomal dominant disorder that affects about one subject out of 4000. NF1 gene localized in 17q11.2 is of about 335 kilobases and encodes a 2818 amino-acid protein, neurofibromin. It is a tumor-suppressor gene. Mutations have been identified along the whole gene without hotspots. In the same family in which all subjects have inherited of the same NF1 mutation, patients have different phenotypes, from benign to severe. Main complications of neurofibromatosis 1 are tumors that cause morbidity and mortality: plexiform neurofibromas, malignant peripheral nerve sheath tumors, central nervous system tumors. Inactivation of NF1 in tumor cells seems to be associated with a hyperactive Ras. This opens new therapeutic prospects.
引用
收藏
页码:1158 / 1167
页数:10
相关论文
共 72 条
[1]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[2]   GENE FOR VON RECKLINGHAUSEN NEUROFIBROMATOSIS IS IN THE PERICENTROMERIC REGION OF CHROMOSOME-17 [J].
BARKER, D ;
WRIGHT, E ;
NGUYEN, K ;
CANNON, L ;
FAIN, P ;
GOLDGAR, D ;
BISHOP, DT ;
CAREY, J ;
BATY, B ;
KIVLIN, J ;
WILLARD, H ;
WAYE, JS ;
GREIG, G ;
LEINWAND, L ;
NAKAMURA, Y ;
OCONNELL, P ;
LEPPERT, M ;
LALOUEL, JM ;
WHITE, R ;
SKOLNICK, M .
SCIENCE, 1987, 236 (4805) :1100-1102
[3]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[4]   NEUROFIBROMATOSIS TYPE-1 AND RAS-MEDIATED SIGNALING - FILLING IN THE GAPS [J].
BERNARDS, A .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1995, 1242 (01) :43-59
[5]  
Boulandet EG, 2000, HUM MUTAT, V16, DOI 10.1002/1098-1004(200009)16:3<274::AID-HUMU21>3.0.CO
[6]  
2-F
[7]   TARGETED DISRUPTION OF THE NEUROFIBROMATOSIS TYPE-1 GENE LEADS TO DEVELOPMENTAL ABNORMALITIES IN HEART AND VARIOUS NEURAL CREST-DERIVED TISSUES [J].
BRANNAN, CI ;
PERKINS, AS ;
VOGEL, KS ;
RATNER, N ;
NORDLUND, ML ;
REID, SW ;
BUCHBERG, AM ;
JENKINS, NA ;
PARADA, LF ;
COPELAND, NG .
GENES & DEVELOPMENT, 1994, 8 (09) :1019-1029
[8]   SEQUENCE HOMOLOGY SHARED BY NEUROFIBROMATOSIS TYPE-1 GENE AND IRA-1 AND IRA-2 NEGATIVE REGULATORS OF THE RAS CYCLIC-AMP PATHWAY [J].
BUCHBERG, AM ;
CLEVELAND, LS ;
JENKINS, NA ;
COPELAND, NG .
NATURE, 1990, 347 (6290) :291-294
[9]  
Carey JC, 1999, AM J MED GENET, V89, P7, DOI 10.1002/(SICI)1096-8628(19990326)89:1<7::AID-AJMG4>3.3.CO
[10]  
2-R